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general practitioners views on prescribing,
polypharmacy and potentially inappropriate
prescribing in older people
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OPTI-SCRIPT study team
Abstract
Background: Potentially inappropriate prescribing (PIP) is common in older people in primary care, as
evidenced by a significant body of quantitative research. However, relatively few qualitative studies have
investigated the phenomenon of PIP and its underlying processes from the perspective of general
practitioners (GPs). The aim of this paper is to explore qualitatively, GP perspectives regarding prescribing and PIP
in older primary care patients.
Method: Semi-structured qualitative interviews were conducted with GPs participating in a randomised controlled trial
(RCT) of an intervention to decrease PIP in older patients (≥70 years) in Ireland. Interviews were conducted with GP
participants (both intervention and control) from the OPTI-SCRIPT cluster RCT as part of the trial process evaluation
between January and July 2013. Interviews were conducted by one interviewer and audio recorded. Interviews were
transcribed verbatim and a thematic analysis was conducted.
Results: Seventeen semi-structured interviews were conducted (13 male; 4 female). Three main, inter-related themes
emerged (complex prescribing environment, paternalistic doctor-patient relationship, and relevance of PIP concept).
Patient complexity (e.g. polypharmacy, multimorbidity), as well as prescriber complexity (e.g. multiple prescribers, poor
communication, restricted autonomy) were all identified as factors contributing to a complex prescribing environment
where PIP could occur, as was a paternalistic-doctor patient relationship. The concept of PIP was perceived to be of
variable usefulness to GPs and the criteria to measure it may be at odds with the complex processes of prescribing for
this patient population.
Conclusions: Several inter-related factors contributing to the occurrence of PIP were identified, some of which may be
amenable to intervention. Improvement strategies focused on improved management of polypharmacy and
multimorbidity, and communication across primary and secondary care could result in substantial improvements in PIP.
Trial registration: Current controlled trials ISRCTN41694007
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Background
People over the age of 65 years have a higher prevalence of
multimorbidity (commonly defined as the presence of two
or more chronic medical conditions), requiring multiple
medications (polypharmacy) to manage symptoms and pre-
vent future events.. These combined health care needs,
coupled with age-related changes in pharmacokinetics and
pharmacodynamics make prescribing in this population a
complex task [1–3]. Consequently, evidence indicates that
prescribing in older people is often suboptimal, with an
increased risk for adverse outcomes including drug-drug
interactions, adverse drug reactions and potentially in-
appropriate prescribing [4, 5]. Potentially inappropriate
prescribing (PIP) comprises a number of suboptimal pre-
scribing practices, including inappropriate dose or duration
of medication, drug–drug interactions, drug–disease inter-
actions, and use of medications that have a significant risk
of an adverse drug event (ADE) [6].
In recent years, PIP in older patients has become an im-
portant public health concern, and a significant body of
research has emerged on the topic. A recent systematic
review identified 36 published tools to assess PIP in older
people, the majority of which were explicit (i.e. lists of
drugs to avoid) [7]. There is little overlap between the
tools in terms of which medications are considered in-
appropriate but commonalities include the use of long-
acting benzodiazepines, the use of tricyclic antidepressants
(TCAs), and Non-Steroidal Anti-Inflammatory Drugs
(NSAIDs) in combination with other medications (e.g.
warfarin) [8]. Quantitative studies have estimated the
prevalence of PIP in primary care between 20 - 50 % in
older patients, depending on which of these tools has been
applied [9–11]. Commonly reported consequences of
PIP include increased morbidity, ADEs, hospitalisa-
tions, and lower health related quality of life [4, 12,
13]. The most important risk factor for having PIP is
polypharmacy [14]. Polypharmacy may describe pre-
scribing of many drugs (appropriately) or too many
drugs (inappropriately) [15]. A limited number of rando-
mised controlled trials (RCTs) in primary care have found
pharmacist interventions, computerised decision support
systems (CDSSs) and multifaceted interventions (involving
more than one intervention component) to be somewhat
effective in reducing PIP [16].
Relatively few qualitative investigations into the phe-
nomenon of PIP and the processes underlying it have
been published to date. A recent meta -synthesis identi-
fied seven papers exploring PIP in older people qualita-
tively, highlighting that some doctors have self-perceived
restrictions with regard to prescribing appropriately be-
cause of a combination of factors such as patient expect-
ation, tension between experience and guidelines and
prescriber fear [17]. The majority of the included studies
in this meta -synthesis [17] focused on the experience of
prescribing based on single medications (e.g. benzodiaze-
pines) rather than polypharmacy or PIP and only three
included perspectives of general practitioners (GPs),
highlighting a dearth of information in this area. While it is
crucial to determine the prevalence of PIP, the conse-
quences of PIP, and how best to reduce it, it is also essen-
tial to explore the perspectives of clinicians in relation to
PIP to better inform interventional strategies. The aim of
this paper is to explore GP perspectives regarding
prescribing and PIP in older primary care patients.
Methods
Context and study setting
This study is part of a larger research project conducted in
Irish primary care: the OPTI-SCRIPT study (OPTImizing
PreSCRIbing for Older People in Primary Care, a clusTer
randomized controlled trial). The detailed trial methods
and results have been published elsewhere [18–20]. Briefly,
this was a cluster RCT involving 21 GP practices and 196
patients which found that a multifaceted intervention was
effective in reducing PIP in the intervention group. The
intervention comprised: academic detailing with a pharma-
cist on conducting GP-led medicines review with partici-
pating patients; medicines reviews supported by web-based
pharmaceutical treatment algorithms for GPs providing
evidence-based alternative treatments for specific PIP medi-
cines identified per patient by the research pharmacist (see
Appendix for full list [19]); and tailored patient information
leaflets. A mixed methods process evaluation was con-
ducted as part of the trial. The process evaluation explored
the implementation of the intervention, the experiences of
those participating in the RCT, and lessons for future im-
plementation [21]. The qualitative component of this eva-
luation provided an opportunity to explore aspects of PIP
and prescription medication use qualitatively with GPs
using a thematic analysis.
Study population
All interview participants were recruited from the OPTI-
SCRIPT study between January and July 2013. The lead
study GP in all 21 participating practices, in both the
intervention and control arms, was asked to participate in
a semi-structured interview, 17 of whom were available
for interview (two were on leave and two were unable to
schedule an interview within the study time frame).
Data collection
Data were collected from one to one semi-structured in-
terviews. Semi-structured interviews were the preferred
method of data collection as it is a flexible approach,
allowing interviewers to alter the sequence of questions
or the way in which they are phrased in response to the
participants [22]. All interviews were conducted either
in person (in a setting of the participants preference) or
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via telephone. Telephone interviewing is generally used
where time or costs are issues, and there is evidence that
there is little difference in the quality of the data ob-
tained this way [23, 24]. The interview topic guide cov-
ered aspects of the trial evaluation, as well as prescribing
related issues. In particular, the following broad sections
were pertinent to this current study: reflections on pre-
scribing for older patients in primary care; GPs’ attitudes
to the concept of PIP and its perceived relevance in
primary care, as presented in Table 1. All interviews
were audio recorded (on loud speaker for telephone
interviews) and were conducted by one interviewer (BC),
a health services researcher with previous experience of
conducting qualitative interviews and focus groups.
Data analysis
All interviews were audiotaped and transcribed verbatim by
one interviewer (BC). Because the intended analyses fo-
cused only on the content of what was said, the interviews
were transcribed verbatim (including for example errors in
pronunciation/grammar, slang, and emotional expressions
such as laughter) but finer details such as brief hesitations
or changes in intonation were omitted [25]. All participant
data were pseudo-anonymised by assignment of a unique
study ID. A thematic analysis was conducted following a
six-step process [26]. Two researchers (BC, JAC) independ-
ently reviewed the transcripts of the individual interviews
several times to familiarise themselves with the relevant
data. Small sections of data were assigned a code that sum-
marised the content either. Codes with common features
were grouped together in emerging themes, before finally
being assigned to overarching themes [26]. In the write up,
quotations were used as exemplars of key themes. NVivo
10 was used to assist with organizing the data for analysis.
Results
Characteristics of participants
A total of 17 semi-structured interviews were conducted.
The majority of GPs were male (n = 13, 76 %) and 70 %
(n = 12) of interviews were conducted in person (Table 2).
Compared to a national sample of GPs, a greater propor-
tion of study practices were in urban areas and there were
less single-handed practices (Table 2). Three inter-related
themes emerged, namely a complex prescribing environ-
ment, paternalistic doctor-patient relationship, and rele-
vance of PIP as a concept, and are presented below.
Complex prescribing environment
Complexity was a major theme encompassing patient,
prescriber, and environment factors.
GPs felt that polypharmacy, multimorbidity, and patient
heterogeneity, all contributed to complexity at the patient
level. Potential side-effects and drug interactions, and
perceived poor patient medication adherence, further
compounded these difficulties from the GP perspective:
“Well polypharmacy is the main issue. It’s a huge fear
of drug interactions and side effects you know, it’s
always a challenge isn’t it? You end up adding more
and more tablets to the list and do you take time to
review and stop the other ones and all of that?” (GP3)
In tandem with this, treating complex patients resulted
in complexity at the prescriber level, particularly via
fragmentation of care and the involvement of multiple
prescribers. Multimorbidity resulted in the involvement
of multiple prescribers and specialists in patient care,
each adding to or amending a patient’s medication list:
“Yes the eh, constant evolution of a person’s
prescription, the lack of stability, there must be a
formula somewhere, that would be a nice formula to
write, that eh, you know, the complexity of managing
your patient’s repeat prescription increases
exponentially in relation to the number of specialists
they are seeing or something like that.” (GP13)
Multiple prescriber involvement appeared to impinge
on GP prescribing autonomy. GPs reported feeling
Table 1 Broad prescribing related interview questions
Broad questions
Could you tell me a little about your experience of prescribing for your
older patients
Prompts: multimorbidity; polypharmacy; patient preference/demands
Are you familiar with the concept of PIP or the criteria used to measure
it, aside from this study?
Could you tell me a little about your perspective on PIP / What’s your
view on PIP in primary care?
In your opinion, how is PIP important, relevant to practice?
What is your opinion of the terminology used, PIP?
Table 2 Characteristics of the interview participants compared
to a national sample
Characteristic OPTI-SCRIPT study
N (%)
National estimatesa
%
Number interviewed 17 476
Male (%) 13 (76.4) 69.0
Urban practice location 12 (70.6) 43.0
Single handed practices 3 (17.6) 35.0
>10 years in practice 14 (82.3) No estimate
Interview method:
In person (%) 12 (70.5) N/A
Telephone (%) 5 (29.5)
Average interview
length (minutes)
14.5 (range 8.56 - 26.31) N/A
N/A Not applicable
a Based on a nationally representative sample of GPs from 2005 [52].
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constrained as they were required to issue repeat pre-
scriptions for patients on the General Medical Services
Scheme (GMS) see Table 3, without necessarily having
initiated the prescription:
“Well it limits you eh, very much, the one that stands
out there was a lady with [chronic condition], so all of
her medication, apart from current illness, was in the
hand of the consultant. And of course I had to provide
the script through her medical card system, otherwise I
probably wouldn’t have seen her because it wasn’t
really my prescribing.” (GP9)
Multiple prescribers and multimorbidity further re-
stricted GP prescribing autonomy in terms of the choice
of medications to prescribe when older patients pre-
sented to primary care with acute conditions, with GPs
feeling constrained in terms of their prescribing options:
“…the more complex their prescription, the harder it is
for me to do my job, almost as if, the more specialist
clinics that people are going to, the tighter the
straitjacket I’m on. These elderly people who have a lot
of symptomatic illnesses as well, you know, attend me,
and I have less and less options. If all I had to do was
just care about the person’s headache, or their back
pain, or their pneumonia, I could just do what I would
normally do. But because they are seeing 3 different
specialists and because they are on 3 different suites of
medicines, you know, I have to cognisant of… You
know I’m not complaining about that, it’s just a fact
that it does get difficult. You’ve less and less wiggle
room you know.” (GP13)
Patient and prescriber complexity contributed to a pre-
scribing environment which was characterised as complex
and isolating:
“The complexity of prescribing for the elderly is a
lonely game.” (GP5)
Within this environment, one of the biggest contribut-
ing factors to the occurrence of PIP and general prescrib-
ing errors was poor communication. Communication
between primary and secondary care was identified as
problematic in both directions. However, for the study
participants, the most salient issue was that changes made
in hospital/outpatient settings were often not communi-
cated in a timely manner to inform decision making:
“The real difficulty that we have, ok, is that we are
basically transcribing hospital prescriptions in a lot of
cases onto GMS [General Medical Services Scheme]
scripts, ok, and a lot of the time when we get the
prescriptions, it’s from an outpatient clinic. It might be
in good cases 2 weeks later, in other cases, 5 or 6 months
later when we get a letter of explanation for why the
changes were made, ok, so do we ignore the prescription
until we get an explanation for it?” (GP21)
Paternalistic doctor-patient relationship
Within a paternalistic doctor-patient relationship, the doc-
tor is viewed as the authority figure, acting in the best inter-
est of patient, while the patient cooperates [27]. In general,
GPs in this study characterised themselves in terms of this
type of model. Some GPs clearly adopted an authoritarian/
parental approach to encounters with older patients:
“I mean they will take my lead on this, of course. I
mean if this is what I tell them, em, they will say ‘Yes
doctor, of course’.” (GP9)
“Generally the older patients do as I asked them to do,
and what I mean by compliance is that they mix up
their tablets, but luckily, our local pharmacy now
vacuum pack them for them…I mean I know, it sounds
like baby stuff but to be honest with you, we have
actually gone back to as if you were telling children
when they have to take everything, and it works really
well.” (GP23)
However, it is unclear if this paternalistic model was
employed by choice, or if GPs felt compelled to take
responsibility where patients adopted a more passive ap-
proach to their medication management:
“I mean it certainly amazes me how blindly they will
take increases in their medications, it’s incredible you
know, eh and you know, ‘Oh I’m going to increase your
blood pressure tablet by one, I’m going to add another
anti-cholesterol tablet, O you’re a little bit sleepless
we’ll add another…’, you know, they could walk out of
Table 3 Key features of the Irish primary health care system
• Mixed public and private funding
• Mixed eligibility based on means-testing of income:
○ General Medical Scheme (GMS) card holders (approx. 40 % of
population) entitled to free medical visits but pay a small levy
for dispensed medications
■ All those aged ≥70 years are automatically eligible GMS since
August 2015
○ Doctor visit card (DVC) holders are entitled to free GP visits but
pay for prescriptions in full
○ Private patients pay in full for GP visits and dispensed medications
• GPs must transcribe hospital prescriptions to GMS scripts for
patients to receive prescription medication for free (subject to
prescribing levy)
• GPs are self-employed and are contracted by the State to provide
services to certain populations (e.g. GMS card holders)
• No national register of GPs but it is estimated that there are roughly 2,500
• Routine auditing of prescribing activity does not take place as it
does in countries such as the UK, where most prescribers are
supported by pharmaceutical advisors
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here with three new tablets on their eh, script, they
just accept it.” (GP2)
This passive approach may be a consequence of the
complex medication regimen many patients had, without
fully understanding which medications they were taking
and why:
“…sometimes, people are on tablets and they don’t
know why and the reason that they are on them has
long since passed” (GP22)
GPs also frequently reported that poor communication
was problematic in this patient group, requiring GPs to
take extra measures to get accurate information on patient
adherence:
“Because sometimes, if a tablet is upsetting them, some
of them [patients] can be embarrassed to tell you, and
they just don’t take them, and they end up with a stock
pile, so I ask them to bring everything in.” (GP23)
Perceived value of PIP concept
Most GPs accepted that inappropriate prescribing was
occurring in primary care in these complex patients:
“I’ve no doubt that there is, that we do prescribe
inappropriately. Or that patients are inappropriately
kept on medications for long periods when, in fact,
that medication may have only been prescribed, or
intended for a shorter term, a shorter duration.”
(GP26)
Many GPs were not, however, aware of PIP as a concept
and the published criteria such as the Beers criteria and
STOPP (Screening Tool of Older Person’s Prescriptions)
criteria were not often utilised in routine practice. While
the GPs interviewed were receptive to receiving advice on
prescribing and were keen to improve where possible, a
number were sceptical of the utility of such criteria when
it came to treating such a heterogeneous population:
“I think in the age group we are prescribing for, my X
plus patients who are over 70, are all individuals. They
are individuals themselves, but in fact, they are all on
different cohorts of medications. So I don’t think you can
be, when you look at best practice in prescribing one
agent, you really have to say best practice in prescribing
one agent with maybe, anti-coagulants and maybe,
anti-hypertensives, and maybe, eh, multiple inhalers,
and analgesics at the same time.” (GP5)
Furthermore, a tension existed between specific criteria,
and the risk-benefit of altering medications in the context
of individuals. Where the perceived risk of continuing a
PIP was seen as lower than the potential complications
from altering a medication, GPs were reluctant to make
changes:
“Sometimes, however, for example, in relation to
benzodiazepine, em, you know, somebody might be on
benzodiazepines and has been for 40 years, which one of
the patients actually was, I don’t think it’s appropriate
to stop that. If they’re stable and they can get on with
their lives then I think it would cause more hassle for
them and so on and so forth, so, what might be generally
inappropriate might be specifically appropriate.” (GP1)
The term ‘potentially inappropriate prescribing’ evoked
mixed reactions in the GPs, with six of them reporting
that they found the term particularly negative, value-laden
and accusatory and did not incorporate the difficulties of
prescribing for older patients faced by the GPs, as outlined
above:
“Inappropriate connotes carelessness, and I think very
few of us are careless…” (GP5)
The remaining GP interviewees did not express any
negative feelings towards the terminology or find it to be
problematic:
“Potentially inappropriate prescribing, I think that’s
quite good, actually, because it’s, it’s potentially. It’s
not giving you an absolute.” (GP22)
Discussions
Summary
This study highlights some GPs’ perspectives on PIP and
polypharmacy in older patients. Three inter-related
themes emerged, namely a complex prescribing envi-
ronment, paternalistic doctor-patient relationships, and
a limited relevance of the PIP concept for GPs. GPs
highlighted that prescriber (e.g. multiple prescribers) and
patient (e.g. multimorbidity) factors, and characteristics of
a paternalistic doctor-patient relationship, contributed to
a complex environment in which potentially inappropriate
prescribing could occur. However, the utility of the PIP
concept, and the criteria to measure it, was questioned by
GPs as it often failed to take this complexity into account.
Comparison with existing literature
Consistent with previous qualitative explorations, this
study has highlighted that multiple, inter-related factors
influence PIP [17, 28]. Polypharmacy, multimorbidity,
and fragmentation of care have all been identified as
contributing to a complex prescribing environment [17,
28, 29]. These factors are common risk factors for PIP,
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some of which may be amenable to intervention. At the
patient level, polypharmacy is one of the most consist-
ently reported predictors of PIP [10, 30, 31]. Appropriate
polypharmacy may be improved through a number of
interventional strategies such as the involvement of
pharmacists in pharmaceutical care and strategies focus-
ing on deprescribing [32–34]. However, the evidence
base supporting the mechanisms of how to deprescribe
is limited [35]. Improving the management of patients
with multimorbidity through multifaceted interventions
targeted at risk factors or specific functional difficulties
may potentially improve prescribing, however, the evi-
dence to date is limited [36]. At the prescriber level, the
number of prescribers involved in patient care has been
identified as an important predictor of PIP [37, 38]. Our
findings suggest that fragmentation of care between
multiple prescribers results in poor communication of
up-to-date patient medication information - a finding
which resonates with previous qualitative investiga-
tions on treating patients with multimorbidity [29,
39]. Improving communication systems throughout a
healthcare system is likely to be a difficult task as it
represents a larger system/policy level change. Improving
medicines reconciliation represents one feasible me-
chanism to decreasing medication errors at transitions of
care [40].
Over the last century, the conceptualisation of the
doctor-patient relationship has altered, moving towards
models of shared decision making [27, 41, 42]. Consistent
with previous qualitative findings in a hospital population
[43], our study provides evidence for the continued exist-
ence of a paternalistic doctor-patient relationship in older
patient groups. However, GPs may view this relationship
structure as necessary due to patient confusion with their
complex medication regimens, a passive approach to
medication management, and/or attempts to preserve
their prescribing autonomy [44]. Promoting involvement
of older patients in prescribing decisions, or shared
decision-making, may impact on PIP, as exemplified by
the recent findings of the EMPOWER trial [45]. This
study found that a patient educational tool aimed at
engaging older adults in discussing the harms of benzodi-
azepine use with their physician and/or pharmacist, re-
sulted in significant reductions in benzodiazepine use [45].
However, shared decision-making in this group is likely to
be complicated by polypharmacy, the involvement of mul-
tiple prescribers, and patient knowledge of medication
which is often poor in this group [46, 47]. GPs re-
ported feeling restricted in terms of prescribing au-
tonomy with the choice of treatment often limited by
prescriptions from specialist clinics. In circumstances
like this, shared decision-making regarding prescrip-
tion medication use is likely to be difficult and re-
stricted in scope.
Consistent with previous qualitative findings [28, 48],
GPs in this study reported a limited knowledge of PIP
and published PIP criteria. GPs accepted that PIP may
be occurring, however, there was disagreement between
these participants as to how useful it was to refer to it as
such. A number of GPs found the terminology adversar-
ial and critical. As well as questioning the terminology, a
number of GPs were critical of PIP criteria, highlighting
that it failed to adequately take into consideration the
complexity of an older heterogeneous patient profile, a
common criticism of such criteria. Consequently, the
criteria are often perceived to be limited in terms of
clinical utility and relevance in primary care [49, 50]. In
complex patients perceived as stable, GPs have been
found to prefer to ‘maintain the status quo’, sometimes
referred to as clinical inertia [28, 51]. Our result con-
firmed this, highlighting that particularly in the cases of
medications such as benzodiazepines, where the risk of
stopping the medication is perceived as worse than
continuing it, GPs did not find PIP criteria useful. To be
effective, such tools need be applicable in routine clinical
practice, not only in a research environment. However,
as our study indicates, this gap may not have yet been
successfully bridged in primary care.
Strengths and limitations
This study is an important contribution to the limited
qualitative data in this area. The qualitative methodology
used allowed an exploration of the complexity of PIP in
primary care not accessible in the numerous quantitative,
prevalence studies in the current literature. However, the
present study has a number of limitations. These inter-
views were conducted as part of the OPTI-SCRIPT trial
process evaluation, which limits the findings in two main
ways. Firstly, the process evaluation was designed to ex-
plore elements of intervention implementation and study
participation. Therefore, the topic guide was not designed
to explore the issues outlined in this paper solely, and
interviews were shorter on average (14 minutes) than may
be expected to explore prescribing as a topic. While the
themes presented here emerged strongly from the data,
arguably, a more detailed interview on prescribing and
prescription medication use alone may have produced a
more nuanced account. Secondly, the sample was limited
to only those GPs who participated in the OPTI-SCRIPT
trial. While this resulted in a good response rate, the par-
ticipants may not be representative of GPs nationally.
Study participants were predominantly male, and urban
based and as volunteers to this study, may be more in-
formed about PIP than the general population. However,
when compared to a national sample of GPs, the partici-
pants were broadly similar. Overall, d our results are con-
sistent with the limited number of qualitative studies in
this area, increasing confidence in the findings.
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Conclusions
PIP is common in older populations in primary care.
This study identified several inter-related factors that
contribute to the occurrence of PIP including a complex
prescribing environment, paternalistic doctor-patient re-
lationships and limited relevance of the PIP concept for
GPs. Several of these have been highlighted as amenable
to intervention, including improved management of
polypharmacy and multimorbidity and decreasing PIP.
However, there is a need for stronger evidence of the ef-
fectiveness of such interventions in resulting in clinically
significant patient improvements in patient primary care
[16, 34, 36]. The concept of PIP is perceived to be of
limited usefulness to GPs and the criteria to measure
it may be at odds with the complex processes of
prescribing for this patient population. Future strat-
egies for improving PIP need to be cognisant of such
barriers.
Appendix
Table 4 Selected Prescribing Criteria/Prescribing Indicator [16]
Criteria Concern Estimated prevalence in Irelanda
PPI for peptic ulcer disease at full therapeutic dosage
for > 8 weeks
Earlier discontinuation or dose reduction for
maintenance/ prophylactic treatment of
peptic ulcer disease, oesophagitis or GORD
indicated
4.1- 16.7 %
NSAID (>3 months) for relief of mild joint pain in osteoarthritis Simple analgesics preferable and usually as
effective for pain relief
1.1 - 8.8 %
Long-term (i.e. >1 month), long-acting benzodiazepines e.g.
chlordiazepoxide, flurazepam, nitrazepam, chlorazepate and
benzodiazepines with long-acting metabolites e.g. diazepam
Risk of prolonged sedation, confusion,
impaired balance, falls
3.0-9.1 %
Any regular duplicate drug class prescription e.g. 2 concurrent
opiates, NSAIDs, SSRIs, loop diuretics, ACE inhibitors. Excludes
duplicate prescribing of drugs that may be required on a PRN
basis e.g. Inhaled beta 2 agonists (long and short acting) for
asthma or COPD, and opiates for management of
breakthrough pain
Optimisation of monotherapy within a
single drug class should be observed prior
to considering a new class of drug
2.2 – 6.0 %
TCAs with an opiate or calcium channel blocker Risk of severe constipation 0.4-2.0 %
Aspirin at dose >150 mg/day Increased bleeding risk, no evidence for
increased efficacy
0.1-1.%
Theophylline as monotherapy for COPD/Asthma Risk of adverse effects due to narrow
therapeutic index
0.6-1.2 %
Use of aspirin and warfarin in combination without histamine
H2 receptor antagonist or PPI
high risk of GI bleeding 0.3-1.1 %
Doses of short-acting benzodiazepines, doses greater than: lor-
azepam 3 mg; oxazepam 60 mg; alprazolam 2 mg; temazepam
15 mg; and triazolam 0.25 mg
Total daily doses should rarely exceed the
suggested maximums
1.0-1.5 %
Prolonged use (>1 week) of first generation antihistamines i.e.
diphenydramine, chlorpheniramine, cyclizine, promethazine
Risk of sedation and anticholinergic side
effects
<1.0 %
Warfarin and NSAID together Risk of GI bleeding 0.7-1.7 %
Calcium channel blockers with chronic constipation May exacerbate constipation <1.0 %
NSAID with history of peptic ulcer disease or GI bleeding,
unless with concurrent histamine H2 receptor antagonist, PPI
or misoprostol
Risk of peptic ulcer relapse <1.0 %
Bladder antimuscarinic drugs with dementia Risk of increased confusion, agitation <1.0 %
TCAs with constipation May worsen constipation <1.0 %
Digoxin at a long-term dose > 125 μg/day (with impaired renal
function)
Increased risk of toxicity <1.0 %
<1.0 %
Thiazide diuretic with a history of gout May exacerbate gout <1.0 %
Glibenclamide (with type 2 diabetes mellitus) Risk of prolonged hypoglycaemia <1.0 %
Aspirin with a past history of peptic ulcer disease without
histamine H2 receptor antagonist or PPI
Risk of bleeding <1.0 %
Prochlorperazine or metoclopramide with Parkinsonism Risk of exacerbating Parkinsonism <1.0 %
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